The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 11, 2021

Filed:

Aug. 28, 2018
Applicant:

Psomagen, Inc., Rockville, MD (US);

Inventors:

Zachary Apte, San Francisco, CA (US);

Elisabeth Bik, San Francisco, CA (US);

Sara W. Bird, San Francisco, CA (US);

Luis E. Leon, Santiago, CL;

Pamela A. Nieto, Santiago, CL;

Victor Alegria-Mera, Santiago, CL;

Cristian Bravo, Santiago, CL;

Juan P. Cardenas, Santiago, CL;

Paulo Covarrubias, Santiago, CL;

Sarah L. Gupta, San Francisco, CA (US);

Kira Harman, San Francisco, CA (US);

Juan Jimenez, Santiago, CL;

Felipe Melis-Arcos, Santiago, CL;

Camila F. Navas, Santiago, CL;

Harold Nunez, Santiago, CL;

Eduardo Olivares, Santiago, CL;

Nicolas Ordenes-Aenishanslins, Santiago, CL;

Francisco J. Ossandon, San Francisco, CA (US);

Ignacio Varas, Santiago, CL;

Patricia Vera-Wolf, Santiago, CL;

Donna Marie B. Hongo, San Francisco, CA (US);

Laurens Kraal, San Francisco, CA (US);

Nathaniel A. Walton, San Francisco, CA (US);

Amanda Morton, San Francisco, CA (US);

Juan P. Bustamante, Santiago, CL;

Kwasi Addae, San Francisco, CA (US);

Graham Gass, San Francisco, CA (US);

Katia Soto-Liebe, Santiago, CL;

Juan A. Ugalde, Santiago, CL;

Eduardo H. Morales, Santiago, CL;

Daniel Almonacid, San Francisco, CA (US);

Jessica Richman, San Francisco, CA (US);

Assignee:

PSOMAGEN, INC., Rockville, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/689 (2018.01); C12Q 1/04 (2006.01); C12Q 1/70 (2006.01); G16B 5/00 (2019.01); G16B 20/00 (2019.01); G16B 30/00 (2019.01); G16B 40/00 (2019.01); C12Q 1/6883 (2018.01); G16H 10/40 (2018.01); G16H 50/30 (2018.01); G16H 50/20 (2018.01); G16B 40/20 (2019.01); G16B 40/30 (2019.01); G16B 50/30 (2019.01);
U.S. Cl.
CPC ...
C12Q 1/689 (2013.01); C12Q 1/04 (2013.01); C12Q 1/6883 (2013.01); C12Q 1/705 (2013.01); C12Q 1/708 (2013.01); G16B 5/00 (2019.02); G16B 20/00 (2019.02); G16B 30/00 (2019.02); G16B 40/00 (2019.02); G16H 10/40 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/16 (2013.01); G16B 40/20 (2019.02); G16B 40/30 (2019.02); G16B 50/30 (2019.02);
Abstract

Embodiments of a method and/or system for characterizing one or more female reproductive system-related conditions can include determining a microorganism dataset associated with a set of subjects; and/or performing a characterization process associated with the one or more female reproductive system-related conditions, based on the microorganism dataset, where performing the characterization process can additionally or alternatively include performing a female reproductive system-related characterization process for the one or more female reproductive system-related conditions, and/or determining one or more therapies.


Find Patent Forward Citations

Loading…